Survival benefit associated with human anti-mouse antibody (HAMA) in patients with B-cell malignancies Ignacio AzinovicGerald L. DeNardoSally J. DeNardo Original Article 22 February 2006 Pages: 1451 - 1458
Increased liver temperature efficiently augments human cellular immune response: T-cell activation and possible monocyte translocation Yohei KidaSachiyo Tsuji-KawaharaMasaaki Miyazawa Original Article 21 February 2006 Pages: 1459 - 1469
Mechanism of action differences in the antitumor effects of transmembrane and secretory tumor necrosis factor-alpha in vitro and in vivo Qingfen LiLi LiZhuoya Li Original Article 23 March 2006 Pages: 1470 - 1479
In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line Saskia J. A. M. SantegoetsMarco W. J. SchreursTanja D. de Gruijl Original Article 09 February 2006 Pages: 1480 - 1490
Antitumor effects of a xenogeneic survivin bone marrow derived dendritic cell vaccine against murine GL261 gliomas Michael J. CiesielskiLisa ApfelRobert A. Fenstermaker Original Article 17 February 2006 Pages: 1491 - 1503
A mechanistic study of immune system activation by fusion of antigens with the ligand-binding domain of CTLA4 Dhanalakshmi ChinnasamyMatt TectorMartin K. Oaks Original Article 13 April 2006 Pages: 1504 - 1514
STEAP, a prostate tumor antigen, is a target of human CD8+ T cells Pedro M. S. AlvesOlivier FaureKostas Kosmatopoulos Original Article 19 April 2006 Pages: 1515 - 1523
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma Ying Waeckerle-MenEdith Uetz-von AllmenSilke Gillessen Original Article 13 April 2006 Pages: 1524 - 1533
Macrophage inflammatory protein (MIP)1α and MIP1β differentially regulate release of inflammatory cytokines and generation of tumoricidal monocytes in malignancy Anamika NathSreya ChattopadhyaNawal K. Sharma Original Article 04 March 2006 Pages: 1534 - 1541
CD40 ligation restores cytolytic T lymphocyte response and eliminates fibrosarcoma in the peritoneum of mice lacking CD4+ T cells Andrew LodgePing YuJoel Shilyansky Original Article 21 February 2006 Pages: 1542 - 1552
Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer Paal F. BrunsvigSteinar AamdalGustav Gaudernack Original Article 21 February 2006 Pages: 1553 - 1564
Endoglin (CD105) is a target for an oral DNA vaccine against breast cancer Sung-Hyung LeeNoriko MizutaniRalph A. Reisfeld Original Article 25 March 2006 Pages: 1565 - 1574
Identification of a new HLA-A*0201-restricted cytotoxic T lymphocyte epitope from CML28 Jun-Feng HanTing-Ting ZhaoYu-Zhang Wu Original Article 14 March 2006 Pages: 1575 - 1583
Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICA Stefan HoldenriederPetra StieberHelmut Rainer Salih Original Article 25 April 2006 Pages: 1584 - 1589
Target-selective activation of a TNF prodrug by urokinase-type plasminogen activator (uPA) mediated proteolytic processing at the cell surface Jeannette GerspachJulia NémethKlaus Pfizenmaier Original Article 25 April 2006 Pages: 1590 - 1600
